[Monitoring of postmenopausal women treated with tamoxifen for breast carcinoma].
The aim of this study was to evaluate the usefulness of different diagnostic tools in the screening for endometrial neoplasms in women receiving tamoxifen as adjuvant treatment after surgery for breast cancer. The Authors' experience, while confirming the importance of a very strict and careful follow-up, stresses the higher sensitivity and specificity of diagnostic hysteroscopy.
Istituto di I Clinica Ostetrica e Ginecologica, Università degli Studi di Bari.
S
S
Epifani
S
S
Lattarulo
R
R
Maiorino
G
G
Fabiano
D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D016889:Endometrial Neoplasms / Q000139:chemically induced* / Q000453:epidemiology; D005260:Female; D006801:Humans; D008875:Middle Aged; D008991:Monitoring, Physiologic; D017698:Postmenopause; D012307:Risk Factors; D013629:Tamoxifen / Q000009:adverse effects*
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen